21
TITLE: Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine beta-hydroxylase inhibitor. Etamicastat metabolism and excretion  Full Text
AUTHORS: Ana I Loureiro; Jose F Rocha; Carlos Fernandes Lopes; Teresa Nunes; Lyndon C Wright; Luis Almeida; Patricio Soares da Silva ;
PUBLISHED: 2014, SOURCE: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 77, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
23
TITLE: Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Integrated analysis of pooled data from double-blind phase III clinical studies. ESL in the Treatment of Focal-Onset Seizures   Full Text
AUTHORS: Gil Nagel, A; Elger, C; Ben Menachem, E; Halasz, P; Lopes Lima, J; Gabbai, AA; Nunes, T; Falcao, A ; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2013, SOURCE: EPILEPSIA, VOLUME: 54, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 72
IN MY: ORCID
30
TITLE: Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel COMT inhibitor, during the first administration to healthy male subjects  Full Text
AUTHORS: Nunes, T; F Rocha; Pinto, R ; Machado, R; Wright, L; Falcao, A; Almeida, L; Soares da Silva, P ;
PUBLISHED: 2012, SOURCE: 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 19
INDEXED IN: WOS
IN MY: ORCID
Page 3 of 10. Total results: 92.